Neuromarketing Services Market Size and Share

Neuromarketing Services Market Analysis by Mordor Intelligence
The neuromarketing services market size was valued at USD 1.88 billion in 2025 and is projected to reach USD 3.68 billion by 2031, growing at a CAGR of 12.09% during 2026-2031. The neuromarketing services market is expanding as brands seek evidence of attention, memory, and emotional response before committing media budgets. Generative AI has increased the number of creative assets that can be produced within a campaign cycle, which has increased the need to test those assets at scale. This has made behavioral validation more important where survey results do not explain whether an advertisement is likely to be remembered. Providers are responding with predictive tools, remote research formats, and services that connect creative performance with commercial outcomes. The neuromarketing services market also faces higher compliance requirements for biometric data and emotion inference, particularly in Europe, which favors providers with established governance capabilities.
Key Report Takeaways
- By type of service, Advertising and Creative Testing Services held 31.81% of the neuromarketing services market share in 2025, while Brand Equity and Implicit Association Testing Services are projected to expand at a 12.98% CAGR through 2031.
- By end-use industry, Consumer Goods held 28.62% of the neuromarketing services market share in 2025, while Healthcare and Pharmaceuticals is projected to grow at a 12.71% CAGR through 2031.
- By geography, North America held 39.41% of the neuromarketing services market share in 2025, while Asia-Pacific is projected to expand at a 12.84% CAGR through 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
Global Neuromarketing Services Market Trends and Insights
Drivers Impact Analysis*
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising Need to Improve Advertising ROI | +2.5% | Global, with concentrated spending in North America and Western Europe | Short term (≤ 2 years) |
| AI-Enabled Multimodal Analytics and Faster Insight Delivery | +2.1% | Global, led by North America and Asia-Pacific technology hubs | Short term (≤ 2 years) |
| Shift From Self-Reported Surveys to Subconscious Measurement | +1.7% | Global, with strongest adoption pressure in North America and Europe | Medium term (2-4 years) |
| Expansion of UX, Digital Journey, and Shopper Optimization Use Cases | +1.4% | North America, Western Europe, and Asia-Pacific E-Commerce Markets | Medium term (2-4 years) |
| Retail Media Creative Proliferation Increases Pre-Launch Testing Demand | +1.1% | North America and Western Europe, with growing relevance in Asia-Pacific | Short term (≤ 2 years) |
| GenAI Asset Volume Raises Need for Scalable Neuroscience-Led Validation | +0.9% | Global, with initial concentration in the United States and United Kingdom | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
Rising Need to Improve Advertising ROI
The need to improve advertising return on investment supports demand across the neuromarketing services market. Reach and exposure measures do not show whether a campaign created attention, encoded a memory, or prompted an emotional response. This gap is important when marketing teams must defend spending decisions with evidence tied to sales outcomes and compare multiple creative alternatives before approving a media plan. Adverteyes stated that its PreView product uses 18 million human observations from 90 countries and more than 350 billion video frames to connect attention and emotional responses with advertising outcomes.[1]Adverteyes, “Press Release: Realeyes Announces Launch of Adverteyes,” Adverteyes, adverteyes.ai Mars reported up to 19% sales lift and USD 18 million in advertising optimizations across 19 markets from creative intelligence linked to sales data, according to Adverteyes. These results make validated attribution more relevant in agency procurement and can encourage more consistent reporting formats across the neuromarketing services market.
AI-Enabled Multimodal Analytics and Faster Insight Delivery
Artificial intelligence is shortening the time required to process neural and physiological research data in the neuromarketing services market. A 2025 literature review found that AI can analyze neural and physiological datasets and produce campaign-level emotional impact measures.[2]Haj-Salem and W. El-Manstrly, “The Synergy of Neuromarketing and Artificial Intelligence: A Comprehensive Literature Review in the Last Decade,” Future Business Journal, springer.com These capabilities allow providers to test a larger volume of creative material across formats without expanding study timelines in the same proportion. In May 2026, iMotions released its Affectiva Emotion SDK for Android, which provides on-device facial expression and emotion-recognition inference for mobile devices, kiosks, vehicle systems, and immersive devices. Faster processing and edge deployment can widen the range of research, thereby lengthening study timelines in rch settings available to the neuromarketing services market.
Shift From Self-Reported Surveys to Subconscious Measurement
Self-reported research does not always capture the attention and emotional responses that arise during a purchase decision. A 2025 study found that EEG, galvanic skin response, and facial coding can capture attention and emotional dynamics at stages of the buying process that conventional self-report tools do not measure. The neuromarketing services market benefits when clients need to examine implicit reactions rather than stated preferences alone. This need is particularly relevant for brands evaluating visual identity, packaging, and advertising assets that may have accumulated unintended associations. Split Second Research reported that a study across the United States and China used implicit testing to identify visual elements that had moved toward a competitor in consumers' intuitive responses. The result supports demand for services that assess associations formed over time, rather than relying only on a respondent's conscious explanation.
Expansion of UX, Digital Journey, and Shopper Optimization Use Cases
The neuromarketing services market is extending beyond advertising pre-testing into website navigation, application flows, store layouts, and omnichannel shopping paths. A 2026 study introduced the Neuroadaptive Retailing Index, combining EEG engagement, galvanic skin response arousal, and eye-tracking measures to assess consumer immersion in hybrid retail settings. This approach broadens the use of behavioral evidence from campaign development to experience design. In June 2026, Tobii launched webcam eye tracking for distributed online research in Tobii Pro Lab. The capability allows researchers to analyze webcam-based gaze data with metrics also used in lab-based research. Remote formats can help the neuromarketing services market include more participants, test digital journeys without laboratory capacity constraints, and compare behavior across locations that would be difficult to include in a conventional in-person study.
Restraints Impact Analysis*
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Tightening Biometric and Emotion AI Compliance Burdens | -1.5% | European Union and United Kingdom Most Severely, With Spillover to North America Through Multinational Companies | Medium term (2-4 years) |
| High Cost of Advanced Neuro and Biometric Studies | -1.2% | Global, Most Acute in Emerging Markets and Among Mid-Market Brand Owners | Long term (≥ 4 years) |
| Neuroprivacy, Consent, and Ethical Manipulation Concerns | -0.9% | Global, With Regulatory Pressure Focused in the European Union, Germany, and the Netherlands | Medium term (2-4 years) |
| Camera Consent Friction and Remote Sample Quality Volatility | -0.6% | Global, With Heightened Relevance in Privacy-Conscious Markets | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
Tightening Biometric and Emotion AI Compliance Burdens
Compliance requirements can limit deployment choices in the neuromarketing services market. Article 5(1)(f) of the EU AI Act, effective February 2, 2025, prohibits the placing on the market or use of AI systems that infer emotions in workplace and educational settings, except for limited medical or safety uses. European Commission guidance published in April 2025 distinguished observing an expression from inferring an emotion, which has direct consequences for facial-coding services. The Dutch Data Protection Authority also described AI emotion recognition as questionable and risky under the General Data Protection Regulation, including in consumer research settings. Providers must therefore maintain clear consent processes and distinguish data collection from emotion inference. These requirements increase operational complexity and may concentrate European work among providers capable of maintaining compliance across multiple regulatory frameworks.
High Cost of Advanced Neuro and Biometric Studies
The cost of advanced research limits access to some parts of the neuromarketing services market. Full-spectrum studies that combine EEG, functional magnetic resonance imaging, and biometric monitoring require specialized equipment, facilities, and technical staff. The resulting cost can place multi-modal research beyond the budgets of many mid-market brands. Larger consumer goods companies can therefore use more intensive studies, while smaller clients may choose lower-cost predictive tools. This can create differences in the depth of evidence available to different client groups. Research budgets can also be reduced during periods of spending restraint because these studies do not always have the recurring contractual status of conventional tracking programs.
*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.
Segment Analysis
By Type: Advertising Testing Holds the Largest Position While Brand Equity Testing Grows Fastest
Advertising and Creative Testing held 31.81% of the neuromarketing services market share in 2025. The service category benefits from pressure on advertisers to connect creative choices with measurable campaign outcomes. Larger volumes of content generated through GenAI have made it harder for teams to rely only on internal review or traditional survey feedback. Providers use attention, memory, and emotional-response measures to assess creative assets before media spending begins, which keeps advertising testing central to the neuromarketing services market.
Brand Equity and Implicit Association Testing is projected to expand at a 12.98% CAGR through 2031. Its growth reflects a shift from evaluating an individual campaign toward examining associations built through repeated brand exposure. A 2026 study found that implicit measurement can capture price-image and quality-image perceptions that explicit surveys may misstate. This supports the use of implicit methods when brands need evidence on whether long-term communications have created durable associations. Shopper and Retail Experience Testing Services and Product, Packaging, and Claims Testing Services address product and digital shopping encounters, while Other Types include clinical and academic research services that continue to develop with neuroimaging capacity, especially in Asia-Pacific.

By End-Use Industry: Consumer Goods Leads While Healthcare and Pharmaceuticals Accelerate
Consumer Goods held 28.62% of the neuromarketing services market share in 2025. The sector has long used behavioral research for shelf arrangement, packaging design, and advertising assessment. Consumer goods companies make frequent decisions on product presentation and campaign assets, providing recurring use cases for testing services. The category's established demand for research at the shelf and in digital retail supports its leading position within the neuromarketing services market.
Healthcare and Pharmaceuticals is projected to grow at a 12.71% CAGR through 2031. The vertical is using behavioral design testing to assess packaging legibility, dosing-instruction comprehension, and pre-launch communication. Packaging usability can influence how patients interpret and use a medicine, making visual and cognitive evidence relevant during development. Split Second Research reported that a 2026 study of a pharmaceutical brand's United States launch evaluated 5 pack designs and identified the combination of color, font, and tagline with the strongest consumer response.[3]Split Second Research, “Crossing the Atlantic: How a Five-Platform Pack Testing Study Identified the Right Design for a US Market Launch,” Split Second Research, splitsecondresearch.co.uk Media and Entertainment uses facial coding and biometric measures for content pacing, trailers, and in-game advertising, while Financial Services, Automotive and Mobility, and IT and Telecommunications are adopting eye tracking and engagement measures for interfaces, onboarding flows, and in-vehicle systems.

Geography Analysis
North America held 39.41% of the neuromarketing services market share in 2025, supported by established purchasing practices among consumer goods and media companies. The region integrates behavioral evidence into advertising planning more deeply than many other markets. In May 2026, NielsenIQ launched Motivations IQ in Canada with GOcxm to combine shopper, panel, and demographic data with a motivational framework. The development links consumer motivation with business actions, while the United States has a large concentration of neuromarketing providers and clients across consumer goods, media, financial services, and automotive.
Asia-Pacific is projected to grow at a 12.84% CAGR through 2031, which gives the region the strongest forecast expansion in the neuromarketing services market. In March 2026, Hakuhodo DY ONE and NeU announced joint research on video advertising that examined attention and emotional mechanisms in the Attention to Action creative framework.[4]Hakuhodo DY ONE, “Hakuhodo DY ONE and NeU Launch Joint Research to Visualize the True Value of Video Advertising with ‘Neuromarketing x Creative,’” Hakuhodo DY ONE, hakuhodody-one.co.jp A 2026 article in Distribution and Information examined how AI and neuroscience affect the collection, storage, and commercial use of brain-information data. South Korea has also applied fNIRS research to product design, including a 2025 study of Korean red ginseng packaging. China, India, Japan, and South Korea therefore contribute different sources of demand, including research programs, e-commerce usability testing, and laboratory-based experimentation.
Europe was the second-largest regional segment in 2025, supported by research infrastructure and consumer brand headquarters in the United Kingdom, Germany, France, Italy, and Spain. The EU AI Act increases entry barriers for smaller providers but also creates demand for compliant methods that distinguish biometric collection from emotion inference. This regulatory setting may reduce the number of providers able to operate across European markets. South America remains an emerging part of the neuromarketing services market, with adoption concentrated among multinational consumer goods subsidiaries conducting cross-regional studies, while the Middle East and Africa is the smallest regional segment but shows growing demand for shopper research in the United Arab Emirates and South Africa.

Competitive Landscape
The neuromarketing services market is moderately fragmented, and no single provider leads across every service type. Competition separates into AI-native platforms that provide predictive creative intelligence and multi-modal specialists that compete on the breadth and quality of biometric data collection. DAIVID, Neurons, and Adverteyes are scaling predictive approaches for large volumes of advertising content. iMotions, Tobii AB, and Neuro-Insight compete through multi-sensor research and measurement methods.
Nielsen is expanding its advertising measurement capability through Ad Intel AI, which it launched in July 2026 as a global platform for competitive advertising data and media intelligence. The offering covers competitor strategy, spending, creative analysis, and market opportunity identification. In February 2026, DAIVID partnered with Mortar AI to add creative effectiveness data to marketing mix modeling. In April 2026, DAIVID also partnered with ADIN.AI to place creative-effectiveness models inside an enterprise marketing platform, with Ajinomoto as the first client. These moves connect creative measurement with media planning and execution.
Tobii's June 2026 launch of webcam eye tracking in Tobii Pro Lab removes the need for dedicated hardware in some distributed studies. This lowers one barrier to remote study delivery and may increase competition from startups and academic spinouts. Adelaide launched the AU Ecosystem for Creative Partners in July 2026, integrating Adverteyes, DAIVID, Neurons, and other partners with its media-quality metric. Platform aggregation can increase buyer choice but may reduce individual providers' pricing power. Methodology validation, technical certification, and defensible intellectual property remain important because clients need reliable measurement when research results guide high-value creative, product, and customer-experience decisions.
Neuromarketing Services Industry Leaders
The Nielsen Company (US), LLC
Tobii AB
Cadwell Industries, Inc.
iMotions A/S
Compumedics Limited
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- July 2026: Nielsen launched Ad Intel AI, described as the first global, independent AI-powered platform transforming fragmented advertising data into real-time, actionable media intelligence. The platform covers competitor strategy, spend, creative analysis, and market opportunity identification, representing a significant expansion of Nielsen's footprint at the intersection of advertising measurement and neuromarketing-derived creative evaluation.
- June 2026: Tobii AB released webcam eye tracking for distributed online research within Tobii Pro Lab, enabling researchers to import experiments created in Tobii Sticky and analyze webcam-based gaze data using the same metrics applied to lab-based research. This capability substantially extends the geographic and participant-diversity reach of remote eye-tracking studies.
- May 2026: iMotions released the Affectiva Emotion SDK for Android, bringing on-device, privacy-first facial expression and emotion recognition to Android smartphones, tablets, kiosks, smart displays, vehicle systems, and VR/AR headsets. The edge-compute architecture eliminates dependence on cloud transmission, supporting GDPR- and CCPA-aligned deployments across healthcare, automotive, and enterprise research environments.
- April 2026: DAIVID partnered with ADIN.AI to embed DAIVID's AI-driven creative effectiveness models directly into ADIN.AI's enterprise marketing platform. The integration creates a live loop between creative intelligence and media execution, enabling real-time creative performance prediction and optimization. The partnership launched live with Ajinomoto as its first client.
- March 2026: Hakuhodo DY ONE and NeU Co., Ltd. in Japan announced a joint research project applying neuromarketing technology to verify the effect of video advertising, specifically validating the attentional and emotional mechanisms underlying the Attention to Action creative framework. Results were presented at a March 25, 2026 seminar.
Global Neuromarketing Services Market Report Scope
The Neuromarketing Services Market Report is Segmented by Type of Service (Advertising and Creative Testing, Shopper and Retail Experience Testing, Product, Packaging and Claims Testing, Brand Equity and Implicit Association Testing, and Other Types of Services), End-Use Industry (Consumer Goods, Media and Entertainment, Healthcare and Pharmaceuticals, Financial Services, Automotive and Mobility, IT and Telecommunications, and Other End-Use Industries), and Geography (North America, South America, Europe, Asia-Pacific, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).
| Advertising and Creative Testing |
| Shopper and Retail Experience Testing |
| Product, Packaging and Claims Testing |
| Brand Equity and Implicit Association Testing |
| Other Type of Services |
| Consumer Goods |
| Media and Entertainment |
| Healthcare and Pharmaceuticals |
| Financial Services |
| Automotive and Mobility |
| IT and Telecommunications |
| Other End-Use Industries |
| North America | United States |
| Canada | |
| Mexico | |
| South America | Brazil |
| Argentina | |
| Rest of South America | |
| Europe | United Kingdom |
| Germany | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | Saudi Arabia |
| United Arab Emirates | |
| South Africa | |
| Rest of Middle East and Africa |
| By Type of Service | Advertising and Creative Testing | |
| Shopper and Retail Experience Testing | ||
| Product, Packaging and Claims Testing | ||
| Brand Equity and Implicit Association Testing | ||
| Other Type of Services | ||
| By End-Use Industry | Consumer Goods | |
| Media and Entertainment | ||
| Healthcare and Pharmaceuticals | ||
| Financial Services | ||
| Automotive and Mobility | ||
| IT and Telecommunications | ||
| Other End-Use Industries | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
| Europe | United Kingdom | |
| Germany | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Middle East and Africa | Saudi Arabia | |
| United Arab Emirates | ||
| South Africa | ||
| Rest of Middle East and Africa | ||
Key Questions Answered in the Report
What is the forecast size of the neuromarketing services market?
The neuromarketing services market is projected to reach USD 3.68 billion by 2031, from USD 1.88 billion in 2025, at a 12.09% CAGR during 2026-2031.
What is driving demand for neuromarketing services?
Brands are seeking better evidence of attention, memory, and emotional response before investing in advertising, packaging, and digital experiences.
Which neuromarketing service has the largest share?
Advertising and Creative Testing Services held 31.81% of revenue in 2025, making it the leading service category.
Which end-use sector is growing the fastest?
Healthcare and Pharmaceuticals is projected to expand at a 12.71% CAGR through 2031 as companies test packaging, instructions, and communications.
Which region is expected to grow the fastest?
Asia-Pacific is projected to grow at a 12.84% CAGR through 2031, supported by research activity, digital commerce, and laboratory development.
How do biometric data rules affect providers?
Biometric and emotion-AI rules require clear consent and compliant methodologies, particularly in Europe, raising the operational threshold for providers and increasing the value of documented governance processes for international client programs across complex jurisdictions.
Page last updated on:




